Medicaid Drug Utilization Review (DUR) Board Meeting Agenda for March 23, 2009
The New York State Medicaid Drug Utilization Review Board will meet on March 23, from 9:00 a.m. to 5:00 p.m., Empire State Plaza, Room 3, Concourse, Albany, NY.
- Update of Medication Therapy Management Program
- American Drug Utilization Review Society (ADURS) Conference Report
- Topical Immunomodulators Presentation and Discussion of Utilization
- Update of Prescriber Education Program
- Palivizumab Presentation and Discussion of Utilization
- Update of Psychiatric Services and Clinical Knowledge Enhancement System (PSYCKES)
- Review of Anti-Psychotic Medication RetroDUR Criteria
The Board will deliberate on Medicaid pharmacy initiatives and processes relating to appropriate, medically necessary prescribing and medical standards and criteria for the retrospective and prospective Drug Utilization Review program.
Agenda Timeline (subject to change based on meeting proceedings)
|9:00 - 9:15||Welcome and Introductions|
|9:15 - 10:15||Public Comment Period*|
|10:15 - 10:30||Update of Medication Therapy Management Program|
|10:30 - 10:45||American Drug Utilization Review Society (ADURS) Conference Report|
|10:45 - 11:00||Break|
|11:00 - 12:00||Topical Immunomodulators Presentation and Discussion of Utilization|
|12:00 - 1:00||Lunch - Executive Session|
|1:00 - 1:30||Update of Prescriber Education Program|
|1:30 - 2:30||Palivizumab Presentation and Discussion of Utilization|
|2:30 - 3:00||Update of Psychiatric Services and Clinical Knowledge Enhancement System (PSYCKES)|
|3:00 - 4:00||Review of Anti-Psychotic Medication RetroDUR Criteria|
|4:00 - 4:10||Final Comments/Adjournment|
*Interested parties must notify the Drug Utilization Review Manager at least one (1) week prior to the meeting of their request to address the Board during the public comment period. Requests may be made by calling 518-486-3209 or e-mailing firstname.lastname@example.org (please reference DUR Board). Public comments are limited to the specific topics on the agenda, must be brief (2 minutes), and the total comment period will not exceed 60 minutes. All written statements up to two (2) pages in length may be received up to one (1) week in advance of the meeting. These statements should summarize key points.
NOTE: Those wishing to submit information greater than two (2) pages in length for DUR Board consideration must do so at least two (2) weeks prior to the date of the meeting or the Board may not have ample time to review the information.
Posted February 23, 2009